Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2022

View Archived Issues

Blockade of HIF-1 leads to ROS overproduction in diabetes

MZE-001 shows promising results in murine and canine models of Pompe disease

S-05014, a novel tyrosinase inhibitor with promising anti-Parkinsonian activity

Discovery of novel peptides as probes for crotamine

Ideaya Biosciences presents POLQ inhibitors

U.S. researchers divulge CDK19 inhibitors

Columbia University discloses CD33/CD45 interaction inhibitors

New IRAK and FLT3 inhibitors described by U.S. investigators

Mirati Therapeutics synthesizes new SOS1 inhibitors

New DNA Damage Response Consortium seeks to advance brain cancer research

Microlyse targets VWF and clears microvascular thrombosis

Code Bio and Takeda collaborate on gene therapies for rare diseases

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Phio's INTASYL-based antiviral compounds against SARS-CoV-2 enter in vivo testing

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

JBC-1847 proven effective against Staphylococcus aureus infection

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Sorrento's STI-9167 shows neutralizing activity against SARS-CoV-2 Omicron variants

Novel target identified for long QT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...